These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17294064)

  • 21. A new model for separation between brain dopamine and serotonin transporters in 123I-beta-CIT SPECT measurements: normal values and sex and age dependence.
    Ryding E; Lindström M; Brådvik B; Grabowski M; Bosson P; Träskman-Bendz L; Rosén I
    Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1114-8. PubMed ID: 15014902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo quantification of dopamine transporters in mice with unilateral 6-OHDA lesions using [11C]methylphenidate and PET.
    Fischer K; Sossi V; von Ameln-Mayerhofer A; Reischl G; Pichler BJ
    Neuroimage; 2012 Feb; 59(3):2413-22. PubMed ID: 21945469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity.
    Jucaite A; Fernell E; Halldin C; Forssberg H; Farde L
    Biol Psychiatry; 2005 Feb; 57(3):229-38. PubMed ID: 15691523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation of dopamine transporter imaging with parkinsonian motor handicap: how close is it?
    Pirker W
    Mov Disord; 2003 Oct; 18 Suppl 7():S43-51. PubMed ID: 14531046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced dopamine transporter density in psychotropic-naive patients with obsessive-compulsive disorder shown by [123I]{beta}-CIT SPECT.
    van der Wee NJ; Stevens H; Hardeman JA; Mandl RC; Denys DA; van Megen HJ; Kahn RS; Westenberg HM
    Am J Psychiatry; 2004 Dec; 161(12):2201-6. PubMed ID: 15569890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different loss of dopamine transporter according to subtype of multiple system atrophy.
    Kim HW; Kim JS; Oh M; Oh JS; Lee SJ; Oh SJ; Chung SJ; Lee CS
    Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):517-25. PubMed ID: 26384682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Left hemispheric predominance of nigrostriatal dysfunction in Parkinson's disease.
    Scherfler C; Seppi K; Mair KJ; Donnemiller E; Virgolini I; Wenning GK; Poewe W
    Brain; 2012 Nov; 135(Pt 11):3348-54. PubMed ID: 23043142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical, neuroimaging, and environmental risk differences in monozygotic female twins appearing discordant for dementia of the Alzheimer type.
    Small GW; Leuchter AF; Mandelkern MA; La Rue A; Okonek A; Lufkin RB; Jarvik LF; Matsuyama SS; Bondareff W
    Arch Neurol; 1993 Feb; 50(2):209-19. PubMed ID: 8431141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A 4-year dopamine transporter (DAT) imaging study in neuroleptic-naive first episode schizophrenia patients.
    Mané A; Gallego J; Lomeña F; Mateos JJ; Fernandez-Egea E; Horga G; Cot A; Pavia J; Bernardo M; Parellada E
    Psychiatry Res; 2011 Oct; 194(1):79-84. PubMed ID: 21831607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
    Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
    Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.
    Seibyl JP; Marek K; Sheff K; Zoghbi S; Baldwin RM; Charney DS; van Dyck CH; Innis RB
    J Nucl Med; 1998 Sep; 39(9):1500-8. PubMed ID: 9744331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET.
    Ishikawa T; Dhawan V; Kazumata K; Chaly T; Mandel F; Neumeyer J; Margouleff C; Babchyck B; Zanzi I; Eidelberg D
    J Nucl Med; 1996 Nov; 37(11):1760-5. PubMed ID: 8917170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of dopaminergic function in frontotemporal dementia using I-FP-CIT single photon emission computed tomography.
    Sedaghat F; Gotzamani-Psarrakou A; Dedousi E; Arnaoutoglou M; Psarrakos K; Baloyannis I; Dimitriadis AS; Baloyannis SJ
    Neurodegener Dis; 2007; 4(5):382-5. PubMed ID: 17622781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered serotonin and dopamine transporter availabilities in brain of depressed patients upon treatment with escitalopram: A [123 I]β-CIT SPECT study.
    Rominger A; Cumming P; Brendel M; Xiong G; Zach C; Karch S; Tatsch K; Bartenstein P; la Fougère C; Koch W; Pogarell O
    Eur Neuropsychopharmacol; 2015 Jun; 25(6):873-81. PubMed ID: 25819144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pinhole SPECT imaging of dopamine transporters correlates with dopamine transporter immunohistochemical analysis in the MPTP mouse model of Parkinson's disease.
    Andringa G; Drukarch B; Bol JG; de Bruin K; Sorman K; Habraken JB; Booij J
    Neuroimage; 2005 Jul; 26(4):1150-8. PubMed ID: 15908232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concordant bilateral Duane's Retraction Syndrome (type 1) in female monozygotic twins.
    Dirani M; Chamberlain M; Garoufalis P; Chen C; Guymer RH; Baird PN
    Clin Exp Ophthalmol; 2006 Jul; 34(5):495-7. PubMed ID: 16872351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overlapping and segregating structural brain abnormalities in twins with schizophrenia or bipolar disorder.
    Hulshoff Pol HE; van Baal GC; Schnack HG; Brans RG; van der Schot AC; Brouwer RM; van Haren NE; Lepage C; Collins DL; Evans AC; Boomsma DI; Nolen W; Kahn RS
    Arch Gen Psychiatry; 2012 Apr; 69(4):349-59. PubMed ID: 22474104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Striatal dopamine transporter availability with [123I]beta-CIT SPECT is unrelated to gender or menstrual cycle.
    Best SE; Sarrel PM; Malison RT; Laruelle M; Zoghbi SS; Baldwin RM; Seibyl JP; Innis RB; van Dyck CH
    Psychopharmacology (Berl); 2005 Dec; 183(2):181-9. PubMed ID: 16175405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deep serotonergic and dopaminergic structures in fetal alcoholic syndrome: a study with nor-beta-CIT-single-photon emission computed tomography and magnetic resonance imaging volumetry.
    Riikonen RS; Nokelainen P; Valkonen K; Kolehmainen AI; Kumpulainen KI; Könönen M; Vanninen RL; Kuikka JT
    Biol Psychiatry; 2005 Jun; 57(12):1565-72. PubMed ID: 15953494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Late Emergence of Parkinsonian Phenotype and Abnormal Dopamine Transporter Scan in Chorea-Acanthocytosis.
    Nagy A; Noyce A; Velayos-Baeza A; Lees AJ; Warner TT; Ling H
    Mov Disord Clin Pract; 2015 Jun; 2(2):182-186. PubMed ID: 30713892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.